Australia markets open in 5 hours 59 minutes

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
26.79+1.81 (+7.25%)
As of 12:55PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate0.930.647.123.07
Low estimate0.850.366.772.43
High estimate1.040.887.313.74
Year ago EPS0.560.852.597.12
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts3333
Avg. Estimate62.94M61.39M314.33M239.06M
Low estimate57.6M56.3M303.9M226.2M
High estimate67.5M68.5M326M250.9M
Year ago sales46.4M42.32M171.55M314.33M
Sales growth (year/est)35.60%45.10%83.20%-23.90%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS0.830.943.883.36
Actual EPS0.560.854.041.56
Difference-0.27-0.090.16-1.8
Surprise %-32.50%-9.60%4.10%-53.60%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate0.930.647.123.07
7 days ago0.930.647.123.07
30 days ago0.930.647.123.07
60 days ago1.851.4210.644.26
90 days ago1.891.4910.764.4
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEGRXIndustrySector(s)S&P 500
Current qtr.66.10%N/AN/AN/A
Next qtr.-24.70%N/AN/AN/A
Current year174.90%N/AN/AN/A
Next year-56.90%N/AN/AN/A
Next 5 years (per annum)2.70%N/AN/AN/A
Past 5 years (per annum)10.31%N/AN/AN/A